Changing the shape of medical research and practice
At Organovo, we design functional human tissues. Our bioprinting technology enables the creation of 3D tissues that more accurately reproduce native tissues.
Our focus is on developing a range of tissue and disease models for medical research and therapeutic applications.
Bioprinting combines the synergistic potential of engineering and biology to create living human tissues that mimic the form and function of native tissues, including dense cellularity and the presence of multiple cell types.
The fully cellular tissues do not require biomaterials or scaffolds for three-dimensionality. Creation is automated and highly reproducible, consistently yielding tissues with in vivo-like micro-architecture.
3D Printing May Revolutionize Drug R&D
Could Organovo’s first commercial device, 3-D liver model for pharma, cut drug R&D costs?
Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications.
Keith Murphy shares his perspective as part of a moderated panel on the future of bio fabrication